Product Information
DEXTROAMP-AMPHET ER 10 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.5111 per EA under NDC 00527551137. Its NADAC has been published 272 times since Oct 21, 2020.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 10 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527551137
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037FDA Approved
12/11/2019
TE Code
AB1
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has been published 272 times since Oct 21, 2020, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5111 per EA |
|---|---|
| All-time high | $0.7862 (Jan 13, 2021) |
| All-time low | $0.3703 (Jul 17, 2024) |
| 52-week high | $0.6088 |
| 52-week low | $0.4861 |
| Median price | $0.5861 |
| Average price | $0.5974 |
| Largest weekly change | +63.7% (Aug 21, 2024) |
| Weeks tracked | 272 |
| Tracking since | Oct 21, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-16.0%
3Y
-11.5%
5Y
-25.9%
All
-34.8%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 10 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 10 MG CAP, manufactured by Lannett Company Inc., is $0.5111 per EA (NDC 00527551137), effective Dec 31, 2025.
How has the price of DEXTROAMP-AMPHET ER 10 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has declined 34.8%. It has been tracked across 272 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 10 MG CAP?
Since Oct 21, 2020, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has ranged from a low of $0.3703 (Jul 17, 2024) to a high of $0.7862 (Jan 13, 2021), with a median of $0.5861 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 10 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 10 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 10 MG CAP?
DEXTROAMP-AMPHET ER 10 MG CAP (NDC 00527551137) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.